(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide

C33H39N5O4 — CID 25141904

IUPAC(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
SMILESO=C(NCCCN1C(=O)CN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
InChIInChI=1S/C33H39N5O4/c39-28-12-11-22-19-36-16-13-24-23-9-4-5-10-26(23)35-31(24)27(36)17-25(22)30(28)32(41)34-14-6-15-38-29(40)20-37(33(38)42)18-21-7-2-1-3-8-21/h1-5,7-10,22,25,27-28,30,35,39H,6,11-20H2,(H,34,41)/t22-,25-,27-,28-,30?/m0/s1
InChIKeyJWWMYVZKMRUQCP-LBSQRKHVSA-N
MW569.71 g/mol
LogP3.44
Rot. Bonds7

About (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide

(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide (PubChem CID 25141904) has the molecular formula C33H39N5O4 and a molecular weight of 569.71 g/mol. Its IUPAC name is (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide.

Molecular Properties

Compound Name(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
PubChem CID25141904
Molecular FormulaC33H39N5O4
Molecular Weight569.71 g/mol
Exact Mass569.30
IUPAC Name(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide
SMILESO=C(NCCCN1C(=O)CN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O
InChIInChI=1S/C33H39N5O4/c39-28-12-11-22-19-36-16-13-24-23-9-4-5-10-26(23)35-31(24)27(36)17-25(22)30(28)32(41)34-14-6-15-38-29(40)20-37(33(38)42)18-21-7-2-1-3-8-21/h1-5,7-10,22,25,27-28,30,35,39H,6,11-20H2,(H,34,41)/t22-,25-,27-,28-,30?/m0/s1
InChIKeyJWWMYVZKMRUQCP-LBSQRKHVSA-N
XLogP3.44
TPSA108.98 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500569.71
LogP ≤ 53.44
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydantoin', 'substructure': 'N/A'}

Analyze (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The IUPAC name of (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide (CID 25141904) is (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide.
What is the SMILES notation for (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The canonical SMILES for (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide is O=C(NCCCN1C(=O)CN(Cc2ccccc2)C1=O)C1[C@H]2C[C@H]3c4[nH]c5ccccc5c4CCN3C[C@@H]2CC[C@@H]1O.
What is the InChIKey of (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
The InChIKey is JWWMYVZKMRUQCP-LBSQRKHVSA-N. The full InChI is InChI=1S/C33H39N5O4/c39-28-12-11-22-19-36-16-13-24-23-9-4-5-10-26(23)35-31(24)27(36)17-25(22)30(28)32(41)34-14-6-15-38-29(40)20-37(33(38)42)18-21-7-2-1-3-8-21/h1-5,7-10,22,25,27-28,30,35,39H,6,11-20H2,(H,34,41)/t22-,25-,27-,28-,30?/m0/s1.
What are the key properties of (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide?
(1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide has a molecular weight of 569.71 g/mol, XLogP of 3.44, 7 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,15R,18S,20S)-N-[3-(3-benzyl-2,5-dioxoimidazolidin-1-yl)propyl]-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxamide is sourced from PubChem (CID 25141904), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).